Lack of Access to Antibiotics Against CRGN
Lack of Access to Antibiotics Against CRGN Read More »
Lack of Access to Antibiotics Against CRGN Why in News? A recent study published in The Lancet Infectious Diseases reveals that less than 7% of patients with carbapenem-resistant Gram-negative (CRGN) infections in low- and middle-income countries (LMICs) receive appropriate antibiotics. This alarming statistic underscores a significant global health challenge, as inadequate access to effective antibiotics […]